Novel protease and polymerase inhibitors for the treatment of hepatitis C virus infection

Author： Sheldon Julie Barreiro Pablo Vincent Vincent

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.16, Iss.8, 2007-08, pp. : 1171-1181

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ABT-450: A Novel Protease Inhibitor for the Treatment of Hepatitis C Virus Infection

Current Medicinal Chemistry, Vol. 21, Iss. 28, 2014-09 ,pp. : 3261-3270

Bentham Science Publishers

Access to resources Recommend Favorite

Novel tripeptide inhibitors of hepatitis C virus NS3 serine protease

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 2, 2003-02 ,pp. : 267-272

Informa Healthcare

Access to resources Recommend Favorite

Telaprevir: A Promising Protease Inhibitor for the Treatment of Hepatitis C Virus Infection

Current Medicinal Chemistry, Vol. 16, Iss. 9, 2009-03 ,pp. : 1115-1121

Bentham Science Publishers

Access to resources Recommend Favorite

MK-5172: a second-generation protease inhibitor for the treatment of hepatitis C virus infection

By Gentile Ivan Buonomo Antonio Riccardo Borgia Federico Zappulo Emanuela Castaldo Giuseppe Borgia Guglielmo

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 5, 2014-05 ,pp. : 719-728

Informa Healthcare

Access to resources Recommend Favorite

Targeting the non-structural proteins of hepatitis C virus: beyond hepatitis C virus protease and polymerase

By Holler Tod P Parkinson Tanya Pryde David C

Expert Opinion on Drug Discovery, Vol. 4, Iss. 3, 2009-03 ,pp. : 293-314

Informa Healthcare

Access to resources Recommend Favorite